logo

Actinium Pharmaceuticals Inc (ATNM) Stock: Exploring a Year of Highs, Lows, and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Actinium Pharmaceuticals Inc’s current trading price is -88.18% away from its 52-week high, while its distance from the 52-week low is -9.02%. The stock’s price range for this period has been between $1.33 and $10.24 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.6 million for the day, a number notably higher than the average daily volume of 0.29 million over the last three months.

Actinium Pharmaceuticals Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $10.24 on 05/14/24, while the lowest price for the same period was registered at $1.33 on 12/04/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Actinium Pharmaceuticals Inc (ATNM) has experienced a quarterly decline of -29.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 37.74M and boasts a workforce of 49 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.5762, with a change in price of -6.4400. Similarly, Actinium Pharmaceuticals Inc recorded 626,755 in trading volume during the last 100 days, posting a change of -84.18%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ATNM stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.

ATNM Stock Stochastic Average

Actinium Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 2.56%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 2.56%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 7.47% and 9.65%, respectively.

ATNM Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -76.18%. However, over the last six months, the performance has been stronger by -85.80%. The price of ATNM decreased -31.25% over the last 30 days. And in the last five days, it has fallen by -14.18%.

Most Popular